Health Trials

Advanced Liposarcoma

1

Review clinical trials related to Advanced Liposarcoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

The investigators hypothesize that the combination of eribulin and zanzalintinib will be tolerable and lead to improved progression-free survival (PFS) as compared to eribulin alone based on historical data.

Participants needed: 18
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Washington University School of MedicineUpdated: Jun 3, 2026Locations: 1
Eligibility criteria

Pathologically proven diagnosis of unresectable or metastatic leiomyosarcoma or... [+16]

Pure well-differentiated liposarcoma or low grade leiomyosarcoma. [+56]

Read more